Vis enkel innførsel

dc.contributor.authorLaunes, Gunvor
dc.contributor.authorHagen, Kristen
dc.contributor.authorSunde, Tor
dc.contributor.authorØst, Lars Gøran
dc.contributor.authorKlovning, Ingrid
dc.contributor.authorLaukvik, Inger Lill
dc.contributor.authorHimle, Joseph A.
dc.contributor.authorSolem, Stian
dc.contributor.authorHystad, Sigurd William
dc.contributor.authorHansen, Bjarne
dc.contributor.authorKvale, Gerd
dc.date.accessioned2020-02-06T10:44:36Z
dc.date.available2020-02-06T10:44:36Z
dc.date.created2019-12-20T15:51:56Z
dc.date.issued2019
dc.identifier.citationFrontiers in Psychology. 2019, 10.2500 1-13.nb_NO
dc.identifier.issn1664-1078
dc.identifier.urihttp://hdl.handle.net/11250/2639990
dc.description.abstractBackground: The Bergen 4-day treatment (B4DT) is a concentrated exposure-based treatment for patients with Obsessive-Compulsive Disorder (OCD) delivered during four consecutive days. The B4DT has in a number of effectiveness studies demonstrated promising results as approximately 90% of patients gain reliable clinical change post-treatment and nearly 70% are recovered on a long-term basis. Methods: The current study is the first randomized controlled trial evaluating the effects of the B4DT. Forty-eight patients diagnosed with OCD were randomized to B4DT, self-help (SH), or waiting list (WL) with 16 patients in each condition. All participants randomized to the B4DT underwent the treatment without any attrition. Results: The B4DT yielded significantly better effects than control conditions on measures of OCD, depression, and generalized anxiety. The response rate (≥35% reduction of the individual patient’s pre-treatment Y-BOCS score) was 93.8% in B4DT, 12.5% in SH and 0% in WL, while remission rate (response criterion is fulfilled and the post-treatment Y-BOCS score is ≤12 points) was 62.5%, 6.3%, and 0%, respectively. Furthermore, patients who had received the B4DT, showed improved work- and social functioning. None of the patients treated with B4DT showed signs of deterioration. In comparison, one patient in the SH condition was in remission, and one showed significant clinical improvement, whereas the remaining showed no change. Conclusion: The results indicate that the B4DT is an effective treatment for patients suffering from OCD.nb_NO
dc.language.isoengnb_NO
dc.publisherFrontiers Medianb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleA randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive- compulsive disorder: The Bergen 4-Day Treatmentnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber1-13nb_NO
dc.source.volume10.2500nb_NO
dc.source.journalFrontiers in Psychologynb_NO
dc.identifier.doi10.3389/fpsyg.2019.02500
dc.identifier.cristin1763491
dc.description.localcodeCopyright © 2019 Launes, Hagen, Sunde, Öst, Klovning, Laukvik, Himle, Solem, Hystad, Hansen and Kvale. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.nb_NO
cristin.unitcode194,67,40,0
cristin.unitnameInstitutt for psykologi
cristin.ispublishedtrue
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal